Literature DB >> 12955647

Disseminated sporotrichosis associated with treatment with immunosuppressants and tumor necrosis factor-alpha antagonists.

Geoffrey S Gottlieb1, Cammie F Lesser, King K Holmes, Anna Wald.   

Abstract

We report a case of disseminated sporotrichosis in a 49-year-old man who was treated with multiple immunosuppressants, including tumor necrosis factor (TNF)-alpha antagonists (etanercept and infliximab), for presumed inflammation arthritis. This case illustrates the potential for infectious complications related to the use of cytotoxic immunosuppressants and anticytokine agents, such as TNF-alpha antagonists.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12955647     DOI: 10.1086/377235

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  15 in total

Review 1.  Sporothrix schenckii and Sporotrichosis.

Authors:  Mônica Bastos de Lima Barros; Rodrigo de Almeida Paes; Armando Oliveira Schubach
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

2.  Cavitating pneumonia after treatment with infliximab and prednisone.

Authors:  S M Arend; E J Kuijper; C F Allaart; W Hissink Muller; J T Van Dissel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-07-23       Impact factor: 3.267

3.  Sporothrix schenckii lymphadentitis in a male with X-linked chronic granulomatous disease.

Authors:  Jessica R Trotter; Panida Sriaroon; David Berman; Aleksandra Petrovic; Jennifer W Leiding
Journal:  J Clin Immunol       Date:  2013-11-16       Impact factor: 8.317

4.  The safety of etanercept for the treatment of plaque psoriasis.

Authors:  Kim A Papp
Journal:  Ther Clin Risk Manag       Date:  2007-06       Impact factor: 2.423

5.  Treatment of experimental colitis in mice with LMP-420, an inhibitor of TNF transcription.

Authors:  Laura P Hale; George Cianciolo
Journal:  J Inflamm (Lond)       Date:  2008-03-10       Impact factor: 4.981

6.  Lymphocutaneous Sporotrichosis during Treatment with Anti-TNF-Alpha Monotherapy.

Authors:  Francesco Ursini; Emilio Russo; Christian Leporini; Marilena Calabria; Caterina Bruno; Cesare Tripolino; Saverio Naty; Rosa Daniela Grembiale
Journal:  Case Rep Rheumatol       Date:  2015-02-10

7.  Sporotrichal Tenosynovitis Diagnosed Helpfully by Musculoskeletal Ultrasonography.

Authors:  Takashi Shimizu; Shosuke Akita; Yoshinori Harada; Eri Oguro; Yasutaka Okita; Minoru Shigesaka; Hidetoshi Matsuoka; Takuro Nii; Satoru Teshigawara; Eriko Kudo-Tanaka; Soichiro Tsuji; Masato Matsushita; Shiro Ohshima; Yoshihiko Hoshida; Jun Hashimoto; Yukihiko Saeki
Journal:  Intern Med       Date:  2017-05-15       Impact factor: 1.271

8.  Recombinant Phage Elicits Protective Immune Response against Systemic S. globosa Infection in Mouse Model.

Authors:  Feng Chen; Rihua Jiang; Yicun Wang; Mingji Zhu; Xu Zhang; Shuai Dong; Hongxi Shi; Li Wang
Journal:  Sci Rep       Date:  2017-02-06       Impact factor: 4.379

9.  Clinical use of anti-TNF therapy and increased risk of infections.

Authors:  Tauseef Ali; Sindhu Kaitha; Sultan Mahmood; Abdul Ftesi; Jordan Stone; Michael S Bronze
Journal:  Drug Healthc Patient Saf       Date:  2013-03-28

10.  Painful linear ulcers: A case of cutaneous sporotrichosis mimicking pyoderma gangrenosum.

Authors:  Kristy Charles; Lori Lowe; Emily Shuman; Kelly B Cha
Journal:  JAAD Case Rep       Date:  2017-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.